Lemaitre Vascular Inc
LMAT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001158895
No open-market purchases or sales by Lemaitre Vascular Inc insiders were filed in the last 90 days; 327 institutions reported holding it in 13F filings for Q2 2026, worth $2.20B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Lemaitre Vascular Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Lemaitre Vascular Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Roberts David B | President and Director | 14,667 | Sep 8, 2026 | 11 |
| Pellegrino Joseph P JR | Director | 15,021 | Sep 8, 2026 | 10 |
| Jasinski Lawrence J | Director | 4,714 | Sep 8, 2026 | 9 |
| Shadan Martha | Director | 2,962 | Sep 8, 2026 | 8 |
| O'Connor John James | Director | 62,827 | Sep 8, 2026 | 9 |
| LeBlanc Dorian Paul | Chief Financial Officer | 2,302 | Sep 8, 2026 | 6 |
| LeMaitre George W | Chairman and CEO | 45,374Indirect | Sep 8, 2026 | 11 |
| Kamke Trent G | Senior V. P., Operations | 3,749 | Sep 8, 2026 | 12 |
| Roush John A | Director | 7,386 | Sep 8, 2026 | 9 |
| Ross Bridget A | Director | 3,942 | May 11, 2026 | 7 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 (view filing) | Feb 27 | 3 days | Kamke Trent GSenior V. P., Operations | SSale | −1.04K | $110.29 | −$115.1K | −13.5%6.68K after | |
| Mar 13, 2026 (view filing) | Mar 11 | 2 days | Roberts David BPresident and Director | SSale | −3.31K | $107.68 | −$356.6K | −18.4%14.7K after | |
| Mar 13, 2026 (view filing) | Mar 11 | 2 days | Kamke Trent GSenior V. P., Operations | SSale | −2.63K | $108.50 | −$284.8K | −28.2%6.68K after | |
| May 11, 2026 (view filing) | May 7 | 4 days | Jasinski Lawrence JDirector | SSale | −3.94K | $110.00 | −$433.7K | −45.5%4.71K after | |
| May 11, 2026 (view filing) | May 7 | 4 days | Ross Bridget ADirector | SSale | −5.04K | $111.10 | −$560.4K | −56.1%3.94K after | |
| May 11, 2026 (view filing) | May 8 | 3 days | Kamke Trent GSenior V. P., Operations | SSale | −2.93K | $107.00 | −$313.3K | −43.9%3.75K after | |
| May 11, 2026 (view filing) | May 7-8 | 4 days | LeMaitre George WChairman and CEO | SSale | −46.5K | $108.27 | −$5.03M | −3.1%1.43M after | 2 lots |